Revision summary
DBT, public labs, BIRAC, a large patient market, and generics plants explain India’s biotech bustle. Farm tools and contract research add demand besides hospitals. Biopharma gained vaccines, biosimilars, recombinant insulin, and diagnostics, including UN-prequalified shots. Gaps are original discovery, trial capital, and slow or split regulation. Policy should keep cheap quality biologics and add a cleaner, faster regulatory clock.
Model answer
Flow diagram
flowchart TD DR[Disease farm market] --> BT[Biotech activity] PUB[DBT BIRAC CSIR] --> BT GEN[Generics GMP skill] --> BT BT --> V[Vaccines biosimilars insulin kits] V --> ACC[Lower cost public programmes] REG[Faster quality regulation] --> V
Conclusion
- One predictable regulator clock for clinical trials and biosimilar pathways, with world-class inspection rather than extra paper.
- Public purchase that rewards quality and new antigens, not only the lowest bid that kills R&D.
- BIRAC-scale funding for translational labs, cluster freeze-dry and fill-finish, and skill in bioprocess engineering.
- Open biopharma to ethical data-sharing for rare diseases while protecting privacy.
- Keep access as the Indian edge: cheap, good-enough biologics for the South, while a few centres chase original discovery.
Biotechnology is busy in India because public science, a huge health and farm market, and a generics culture met global contract demand. Biopharma gained vaccines, biosimilars, insulin, and diagnostics that cut cost and serve immunisation. The next gain is faster clean regulation and more original biologics, without losing the access model.
Quick related
Students also ask
-
Among several factors for India's potential growth, savings rate is the most effective one. Do you agree? What are the other factors available for growth potential?
Next question on this syllabus topic (2017 · Q1). View answer →
-
Is Indian biotech only about GM food?
No. Vaccines, biosimilars, diagnostics, enzymes, and tissue culture are larger in jobs and exports than food GM, which remains limited.
-
Did biopharma only copy foreign drugs?
Much of the gain is process skill, vaccines, and biosimilars. That still lowered prices. First-in-class discovery is the unfinished part.
PYQ trend
When UPSC asked this
Related PYQs from other years, newest first. Open a question to read it.
-
2018 · Q4 · GS III · 10 marks
Examine the role of supermarkets in supply chain management of fruits, vegetables and food items. How do they eliminate number of intermediaries? (150 Words, 10 Marks). -
2018 · Q5 · GS III · 10 marks
Discuss the work of 'Bose-Einstein Statistics' done by Prof. Satyendra Nath Bose and show how it revolutionized the field of Physics. (150 Words, 10 Marks). -
2018 · Q8 · GS III · 10 marks
Sikkim is the first 'Organic State' in India. What are the ecological and economical benefits of Organic State? (150 Words, 10 Marks). -
2018 · Q9 · GS III · 10 marks
The China Pakistan Economic Corridor (CPEC) is viewed as a cardinal subset of China's larger 'One Belt One Road' initiative. Give a brief description of CPEC and enumerate the reasons why India has distanced itself from the same. (150 Words, 10 Marks). -
2018 · Q11 · GS III · 15 marks
How are the principles followed by NITI Aayog different from those followed by the erstwhile planning commission in India?(250 Words, 15 Marks). -
2018 · Q12 · GS III · 15 marks
How would the recent phenomena of protectionism and currency manipulations in world trade affect macroeconomic stability of India? (250 Words, 15 Marks). -
2018 · Q14 · GS III · 15 marks
How has the emphasis on certain crops brought about changes in cropping patterns in recent past? Elaborate the emphasis on millets production and consumption. (250 Words, 15 Marks). -
2017 · Q1 · GS III · 10 marks
Among several factors for India's potential growth, savings rate is the most effective one. Do you agree? What are the other factors available for growth potential?
More from this topic
Q20 · UPSC Mains 2025 · GS III · 15 marks
Why is maritime security vital to protect India's sea trade? Discuss maritime and coastal security challenges and the way forward.
Indian Economy
About nine-tenths of India’s trade volume and most oil still move by sea, so a chokepoint shock is an economic shock. Coastal creeks, 26/11-style gaps, illegal fishing, piracy and a denser Chinese naval presence are the main challenges. Red Sea attacks in 2023–24 showed how quickly freight and insurance can jump. SAGAR, IPOI, IMAC fusion, coastal police and partner patrols are the reply. Ports and shipbuilding make security a growth story, not only a patrol story.
Q16 · UPSC Mains 2025 · GS III · 15 marks
India aims to become a semiconductor manufacturing hub. What are the challenges faced by the semiconductor industry in India? Mention the salient features of the India Semiconductor Mission.
Indian Economy
India designs many chips but still makes few, because fabs need capital, ultra-pure water, chemicals and restricted tools. Geopolitics and long project time add risk. The India Semiconductor Mission (2021) has about ₹76,000 crore for fabs, display, compound semiconductors and packaging. A design-linked incentive targets the talent India already has. Mature nodes and ATMP are the realistic near path; leading-edge logic will follow slowly if at all.
Q12 · UPSC Mains 2025 · GS III · 15 marks
Discuss the rationale of the Production Linked Incentive (PLI) scheme. What are its achievements? In what way can the functioning and outcomes of the scheme be improved?
Indian Economy
PLI is a time-bound payment on extra sales to pull manufacturing scale into India. About fourteen sectors share an outlay near two lakh crore rupees. Mobile assembly and exports are the clearest win; value addition and several heavy sectors lag. Jobs exist mainly in assembly unless design and components deepen. Reform means easier claims, MSME access, export and value-addition metrics, and a sunset.
Toppers' copies
Toppers' copies for this question will be uploaded soon.